Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Gilead Sciences, Inc’s current trading price is -9.18% away from its 52-week high, while its distance from the 52-week low is 75.53%. The stock’s price range during this period has varied between $62.07 and $119.96. The company, active in the Healthcare sector, saw a trading volume of around 6.41 million for the day, considerably lower average daily volume of 9.74 million observed over the last three months.
Gilead Sciences, Inc’s stock has had a calm market performance.
How Financial Performance Impacts Market Capitalization
Gilead Sciences, Inc (GILD) has experienced a quarterly decline of -6.07% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 135.53B and boasts a workforce of 17600 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
How GILD’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for GILD stands at 1.30. Similarly, the long-term debt-to-equity ratio is also 1.16.
GILD Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 17.95%.However, over the last six months, we can see a weaker performance of 19.27%. Over the last 30 days, the price of GILD has fallen by 5.52%. And in the last five days, it has surged by 1.47%.
